Insider · CIK 0001724097
Matt Abernethy
Files at NBIX (NEUROCRINE BIOSCIENCES INC), FATE (FATE THERAPEUTICS INC). First filing Feb 4, 2025, latest Sep 15, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NBIX: NEUROCRINE BIOSCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | NEUROCRINE BIOSCIENCES INC | $363k 2,311 shares | -5% | - | |
| 16Weak | NEUROCRINE BIOSCIENCES INC | $299k 2,558 shares | -7% | - | |
| 12Weak | NEUROCRINE BIOSCIENCES INC | $116k 980 shares | -3% | - | |
| 14Weak | NEUROCRINE BIOSCIENCES INC | $196k 1,283 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock10b5-1 | +5,020 | $0.00 | $0 | 47,828 | 27 d ago |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock10b5-1 | -2,709 | $156.22 | $423k | 45,119 | 27 d ago |
| Sep 14, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -2,311 | $157.20 | $363k | 42,808 | 27 d ago |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +110,000 | $0.00 | $0 | 110,000 | May 30, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +2,566 | $0.00 | $0 | 36,127 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,352 | $116.85 | $158k | 34,775 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +2,241 | $0.00 | $0 | 37,016 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,206 | $116.87 | $141k | 35,810 | Feb 14, 2025 |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Stock Optionderivative10b5-1 | +45,538 | $0.00 | $0 | 45,538 | Feb 14, 2025 |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Restricted Stock Unitderivative10b5-1 | +8,534 | $0.00 | $0 | 8,534 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,566 | $0.00 | $0 | 5,132 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,241 | $0.00 | $0 | 6,725 | Feb 14, 2025 |
| Feb 8, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,860 | $0.00 | $0 | 34,541 | Feb 12, 2025 |
| Feb 10, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -980 | $118.27 | $116k | 33,561 | Feb 12, 2025 |
| Feb 8, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,860 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +2,436 | $0.00 | $0 | 33,964 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,283 | $152.87 | $196k | 32,681 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,436 | $0.00 | $0 | 2,437 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.